基于双模态影像的列线图预测乳腺癌HER2低表达状态
回顾性纳入316例HER2阴性乳腺癌患者,随机分为训练组221例和验证组95例,基于超声和乳腺X线影像特征构建预测HER2低表达的列线图。列线图在训练组AUC为0.783,验证组AUC为0.810,校准良好,决策曲线显示有临床净获益,HER2低表达与改善的无进展生存相关。
要点
- 超声和乳腺X线显示肿瘤径线较长、边缘非 circumscribed、后方声影及较高最大弹性是HER2低表达的独立预测因素。
- 列线图训练组AUC为0.783,验证组AUC为0.810,校准曲线显示校准良好。
- 决策曲线分析提示列线图具有临床实用性,HER2低表达与改善的乳腺癌预后相关。
核心结论
- 基于超声和乳腺X线影像特征的列线图可能为选择适合管理的候选者提供参考。
研究设计与样本
- 回顾性研究,纳入316例HER2阴性乳腺癌患者,随机分为训练组221例和验证组95例,收集超声和乳腺X线图像,通过单因素和多因素分析筛选独立危险因素并构建列线图模型,在验证组进行验证。
关键影像表现/征象
- 超声和乳腺X线图像上肿瘤径线较长、边缘非 circumscribed、后方声影及较高最大弹性是HER2低表达的独立预测因素。
诊断标准与关键数值
- 列线图模型训练组AUC为0.783,验证组AUC为0.810,两组校准效率良好。
- 决策曲线分析表明列线图具有临床实用性。
- Log-rank检验显示两组无进展生存期差异显著,HER2低表达与改善的乳腺癌预后相关。
临床应用与阅片要点
- 原文结论认为该列线图可能为选择适合管理的候选者提供参考。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop and validate a nomogram based on ultrasound and mammographic imaging features for predicting human epidermal growth factor receptor 2-low (HER2-low) expression status in breast cancer.
METHODS: Patients with HER2-negative breast cancer (n = 316) were retrospectively recruited and randomized into training (n = 221) and validation (n = 95) cohorts. Patients were categorized into HER-low and HER2-zero expression groups. Ultrasound and mammography images were collected. Univariate and multivariate analyses were used to identify independent risk factors for HER-low expression status in the training cohort. A predictive nomogram model was developed and validated in the validation cohort. The calibration, discrimination, and clinical net benefit of the nomogram model were assessed using calibration curves, receiver operating characteristic curves, and decision curve analyses, respectively. A Kaplan-Meier curve was drawn, and the log-rank test was used to compare progression-free survival of the two groups of patients.
RESULTS: A longer diameter, tumor margin that was not circumscribed in ultrasound and mammography images, posterior acoustic shadowing, and a higher maximum elasticity were independent predictors of HER2-low expression status; thus, they were incorporated into the nomogram model. The area under the receiver operating characteristic curve (AUC) of the nomogram model was 0.783 in the training cohort. The nomogram also showed good discrimination in the validation cohort (AUC = 0.810), and good calibration efficiency in both cohorts. Decision curve analysis indicated that the nomogram was clinically useful. The log-rank test result revealed a significant difference in progression-free survival. HER2-low expression correlated with improved breast cancer prognosis.
CONCLUSION: This nomogram may provide reference for selecting candidates for appropriate management.
引用
- Li Y, Liang X, Chen J, et al. Nomogram using bi-modal imaging for predicting low-level HER2 expression status in breast cancer. Eur J Radiol. 2025. PMID: 40279920. doi:10.1016/j.ejrad.2025.112118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。